|Bid||0.00 x 900|
|Ask||0.00 x 800|
|Day's range||137.14 - 141.99|
|52-week range||78.06 - 175.00|
|Beta (5Y monthly)||1.81|
|PE ratio (TTM)||N/A|
|Forward dividend & yield||N/A (N/A)|
|1y target est||N/A|
Sarepta Therapeutics, Inc. (NASDAQ:SRPT) shareholders might be concerned after seeing the share price drop 17% in the...
Sarepta Therapeutics (SRPT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Sarepta (SRPT) is seeking accelerated approval for exon 45 amenable DMD candidate, casimersen. Amondys 45 is likely to be the brand name for the candidate.